$TRIL this is relevant and continues to support TRIL's CD-47 program http://www.bioportfolio.com/resources/pmarticle/1281209/Ara-C-and-anti-CD47-antibody-combination-therapy-eliminates-acute-monocytic-leukemia.html -BioHunter